Nrf2, a PPARγ Alternative Pathway to Promote CD36 Expression on Inflammatory Macrophages: Implication for Malaria

English version České info

CD36 is the major receptor mediating nonopsonic phagocytosis of Plasmodium falciparum-parasitized erythrocytes by macrophages. Its expression on macrophages is mainly controlled by the nuclear receptor PPARγ. Here, we demonstrate that inflammatory processes negatively regulate CD36 expression on human and murine macrophages, and hence decrease Plasmodium clearance directly favoring the worsening of malaria infection. This CD36 downregulation in inflammatory conditions is associated with a failure in the expression and activation of PPARγ. Interestingly, using siRNA mediating knock down of Nrf2 in macrophages or Nrf2- and PPARγ-deficient macrophages, we establish that in inflammatory conditions, the Nrf2 transcription factor controls CD36 expression independently of PPARγ. In these conditions, Nrf2 activators, but not PPARγ ligands, enhance CD36 expression and CD36-mediated Plasmodium phagocytosis. These results were confirmed in human macrophages and in vivo where only Nrf2 activators improve the outcome of severe malaria. Collectively, this report highlights that the Nrf2 transcription factor could be an alternative target to PPARγ in the control of severe malaria through parasite clearance.

Vyšlo v časopise: Nrf2, a PPARγ Alternative Pathway to Promote CD36 Expression on Inflammatory Macrophages: Implication for Malaria. PLoS Pathog 7(9): e32767. doi:10.1371/journal.ppat.1002254
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002254

Souhrn

Zdroje

1. TrinchieriGSherA 2007 Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 7 179 190

2. GreenbergMESunMZhangRFebbraioMSilversteinR 2006 Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J Exp Med 203 2613 2625

3. BaranovaINKurlanderRBocharovAVVishnyakovaTGChenZ 2008 Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling. J Immunol 181 7147 7156

4. SerghidesLKainKC 2001 Peroxisome proliferator-activated receptor gamma-retinoid X receptor agonists increase CD36-dependent phagocytosis of Plasmodium falciparum-parasitized erythrocytes and decrease malaria-induced TNF-alpha secretion by monocytes/macrophages. J Immunol 166 6742 6748

5. PatelSNLuZAyiKSerghidesLGowdaDC 2007 Disruption of CD36 impairs cytokine response to Plasmodium falciparum glycosylphosphatidylinositol and confers susceptibility to severe and fatal malaria in vivo. J Immunol 178 3954 3961

6. NagyLTontonozPAlvarezJGChenHEvansRM 1998 Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93 229 240

7. HuangJTWelchJSRicoteMBinderCJWillsonTM 1999 Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 400 378 382

8. BerryABalardPCosteAOlagnierDLaganeC 2007 IL-13 induces expression of CD36 in human monocytes through PPARgamma activation. Eur J Immunol 37 1642 1652

9. SerghidesLPatelSNAyiKLuZGowdaDC 2009 Rosiglitazone modulates the innate immune response to Plasmodium falciparum infection and improves outcome in experimental cerebral malaria. J Infect Dis 199 1536 1545

10. StevensonMMRileyEM 2004 Innate immunity to malaria. Nat Rev Immunol 4 169 180

11. LykeKEBurgesRCissokoYSangareLDaoM 2004 Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect Immun 72 5630 5637

12. BerryACheneGBenoit-VicalFLepertJCBernadJ 2005 Ex vivo and in vitro impairment of CD36 expression and tumor necrosis factor-alpha production in human monocytes in response to Plasmodium falciparum-parasitized erythrocytes. J Parasitol 91 316 322

13. BoyerJFBalardPAuthierHFauconBBernadJ 2007 Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes. Arthritis Res Ther 9 R22

14. NakagawaTNozakiSNishidaMYakubJMTomiyamaY 1998 Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 18 1350 1357

15. NecelaBMSuWThompsonEA 2008 Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor gamma and nuclear factor-kappaB in macrophages. Immunology 125 344 358

16. ThimmulappaRKLeeHRangasamyTReddySPYamamotoM 2006 Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest 116 984 995

17. D'ArchivioMScazzocchioBFilesiCVariRMaggiorellaMT 2008 Oxidised LDL up-regulate CD36 expression by the Nrf2 pathway in 3T3-L1 preadipocytes. FEBS Lett 582 2291 2298

18. IshiiTItohKRuizELeakeDSUnokiH 2004 Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ Res 94 609 616

19. SussanTEJunJThimmulappaRBedjaDAnteroM 2008 Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoE-mediated atherosclerosis in mice. PLoS One 3 e3791

20. SuZFortinAGrosPStevensonMM 2002 Opsonin-independent phagocytosis: an effector mechanism against acute blood-stage Plasmodium chabaudi AS infection. J Infect Dis 186 1321 1329

21. Artavanis-TsakonasKTongrenJERileyEM 2003 The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. Clin Exp Immunol 133 145 152

22. MemonRAFeingoldKRMoserAHFullerJGrunfeldC 1998 Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. Am J Physiol 274 E210 217

23. YesnerLMHuhHYPearceSFSilversteinRL 1996 Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler Thromb Vasc Biol 16 1019 1025

24. KrishnegowdaGHajjarAMZhuJDouglassEJUematsuS 2005 Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J Biol Chem 280 8606 8616

25. ChuangPCWuMHShojiYTsaiSJ 2009 Downregulation of CD36 results in reduced phagocytic ability of peritoneal macrophages of women with endometriosis. J Pathol 219 232 241

26. CosteADubourdeauMLinasMDCassaingSLepertJC 2003 PPARgamma promotes mannose receptor gene expression in murine macrophages and contributes to the induction of this receptor by IL-13. Immunity 19 329 339

27. AfifHBenderdourMMfuna-EndamLMartel-PelletierJPelletierJP 2007 Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes. Arthritis Res Ther 9 R31

28. MracekTCannonBHoustekJ 2004 IL-1 and LPS but not IL-6 inhibit differentiation and downregulate PPAR gamma in brown adipocytes. Cytokine 26 9 15

29. ZhouMWuRDongWJacobAWangP 2008 Endotoxin downregulates peroxisome proliferator-activated receptor-gamma via the increase in TNF-alpha release. Am J Physiol Regul Integr Comp Physiol 294 R84 92

30. KatayamaKWadaKNakajimaAMizuguchiHHayakawaT 2003 A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model. Gastroenterology 124 1315 1324

31. LewisJDLichtensteinGRSteinRBDerenJJJudgeTA 2001 An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis. Am J Gastroenterol 96 3323 3328

32. DubuquoyLJanssonEADeebSRakotobeSKarouiM 2003 Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology 124 1265 1276

33. BoggildAKKrudsoodSPatelSNSerghidesLTangpukdeeN 2009 Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 49 841 849

34. ItohKChibaTTakahashiSIshiiTIgarashiK 1997 An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236 313 322

35. TragerWJensenJB 1976 Human malaria parasites in continuous culture. Science 193 673 675

36. Benoit-VicalFLelievreJBerryADeymierCDechy-CabaretO 2007 Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes. Antimicrob Agents Chemother 51 1463 1472

37. GalèsAConducheABernadJLefevreLOlagnierD 2010 PPARgamma controls dectin-1 expression required for host antifungal defense against Candida albicans. PLoS Pathog 6 e1000714

38. LefèvreLGalèsAOlagnierDBernadJPerezL 2010 PPARgamma ligands switched high fat diet-induced macrophage M2b polarization toward M2a thereby improving intestinal Candida elimination. PLoS One 5 e12828